TITLE

The Effectiveness of Topical Pimecrolimus in the Treatment of Oral Lichen Planus

AUTHOR(S)
Mülayim, Mehmet Kamil; Öztürk, Perihan; Uzun, Soner
PUB. DATE
December 2016
SOURCE
Turkish Journal of Dermatology / Turk Dermatoloji Dergisis;2016, Vol. 10 Issue 4, p152
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Oral lichen planus (OLP) is a chronic inflammatory disorder of unknown etiology that affects the skin and the mucosa, especially the oral mucosa. Several therapeutic agents have been investigated for the treatment of OLP. All agents used in the OLP therapy are palliative. Potent topical steroids are used as the conventional therapy for OLP. Since side-effects or steroid resistance may be encountered, alternative treatments may be necessary. This study aimed to evaluate the efficacy and safety of the topical pimecrolimus in the treatment of OLP. Methods: Seventeen patients with OLP were recruited into this study. Topical pimecrolimus 1% cream was applied twice a day to the affected areas. Patients were followed up for 3-6 months. Photographs of the lesions were taken and analyzed for areas of ulceration, erythema, and reticulation in every clinical examination. Results: We found that topical pimecrolimus 1% cream was an effective treatment for OLP. Two patients could not complete the treatment protocol because of the side effects such as local irritation and nausea. Conclusion: Topical pimecrolimus may be a valuable second treatment choice for patients with steroid-related side-effects or steroid-resistant OLP. However further randomized controlled studies have to be conducted to compare conventional treatment of topical corticosteroid with topical pimecrolimus.
ACCESSION #
120180568

 

Related Articles

  • The Effect of Pimecrolimus Cream 1% Compared with Triamcinolone Acetonide Paste in Treatment of Atrophic-Erosive Oral Lichen Planus. Pakfetrat, Atessa; Delavarian, Zahra; Falaki, Farnaz; Khorashadizadeh, Mahboubeh; Saba, Mina // Iranian Journal of Otorhinolaryngology;Mar2015, Vol. 27 Issue 2, p119 

    Introduction: Oral lichen planus (OLP) is a common chronic mucocutaneous disease. Patients with atrophic and erosive types of OLP often have symptoms of soreness, and require proper treatment. The main treatment for OLP has been the administration of topical or systemic corticosteroids. The...

  • Salivary Cortisol as a Diagnostic Marker in Oral Lichen Planus. Kaur, Beant; Sunil, M. K.; Trivedi, Ashwarya; Singla, Neetu; Garg, Shaveta; Goyal, Navneet // Journal of International Oral Health;2015, Vol. 7 Issue 10, p43 

    Background: Lichen planus (LP) is a common chronic inflammatory diseases of oral mucous membrane and skin. Cortisol, also known as "stress hormone" released by the adrenal gland, has been used as an indicator in various studies related to stress evaluation. The aim and objective of the study...

  • Crohn's Disease: MMF Not the Cure-All for 6-MP/AZA Treatment Failures. Young, R. L.; Thompson, Jon S. // American Journal of Gastroenterology;Jul2000, Vol. 95 Issue 7, p1626 

    Discusses research being done on the efficacy of mycophenolate mofetil (MMF) in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease. Reference to a study by L. Kam and colleagues published in a 2000 issue of "Inflammatory Bowel Disease" journal; Clinical information on...

  • Oral lichen planus: aetiology, diagnosis and treatment. Hegarty, Anne // Dental Nursing;Mar2012, Vol. 8 Issue 3, p141 

    The article focuses on the identification and systemic treatments of oral lichen planus, and the prognosis of affected persons. It states that the chronic inflammatory condition affects the oral mucosa and commonly asymptomatic whit patches. It mentions that oral lesions have been classified...

  • Management of symptomatic erosive.ulcerative lesions of oral lichen planus in an adult Egyptian population using Selenium-ACE combined with topical corticosteroids plus antifungal agent. BELAL, MAHMOUD HELMY // Contemporary Clinical Dentistry;Oct-Dec2015, Vol. 6 Issue 4, p454 

    Aim: Oral lichen planus (OLP) is a chronic mucocutaneous disease with an immunological etiology. This study was conducted to evaluate the effect of selenium combined with Vitamins A, C & E (Selenium-ACE) in the treatment of erosive.ulcerative OLP as an adjunctive to topical corticosteroids plus...

  • Oral lichen planus and epithelial dysplasia with lichenoid features: a review and discussion with special reference to diagnosis. Sanketh, D. SharathKumar; Patil, Shankargouda; Swetha, Balamukundan // Journal of Investigative & Clinical Dentistry;Aug2017, Vol. 8 Issue 3, pn/a 

    Despite guidelines for the diagnosis of oral lichen planus ( OLP), there has been much difficulty and ambiguity in rendering a straightforward diagnosis. The root of the problem might arise in not following universal guidelines and being too rigid and unilateral in making a diagnosis. Because of...

  • Comparing the effects of cryotherapy with nitrous oxide gas versus topical corticosteroids in the treatment of oral lichen planus. Amanat, Dariush; Ebrahimi, Hooman; Zahedani, Maryam Zahed; Zeini, Nasim; Pourshahidi, Sara; Ranjbar, Zahra // Indian Journal of Dental Research;Nov/Dec2014, Vol. 25 Issue 6, p711 

    Background: Oral lichen planus (OLP) is a chronic inflammatory disease of the oral mucosa with treatment challenges for clinicians. Aims: The objective of this study is to compare the effects of cryotherapy as a new modality with topical corticosteroids as a conventional therapy in the treatment...

  • Tx eliminates lice in one course.  // Dermatology Times;Dec2011, Vol. 32 Issue 12, p24 

    The article reports on the study led by dermatologist Nicole Rogers reported at the American Academy of Pediatrics meeting which shows that a topical agent eliminated nearly 90 percent of lice and nits in pediatrics after a single application.

  • Onychomycosis armamentarium set to expand with new options. Krader, Cheryl Guttman // Dermatology Times;Apr2014, Vol. 35 Issue 4, p26 

    The article explores the emerging therapeutic options for onychomycosis. Topics discussed include oral triazole antifungal agents such as albaconazole and posaconazole, topical therapy like Efinaconazole, and lasers. Also mentioned are the importance of accurate diagnosis using the molecular...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics